A significant breakthrough in cancer investigation is occurring with the use of nanobodies to re-engage dysfunctional p53. This vital tumor inhibitor protein is frequently inactivated in many forms of cancer, resulting https://bookmarklayer.com/story21997325/mini-antibodies-restore-p53-a-potential-hope-for-tumor-therapy